- $417.09m
- $693.61m
- $228.83m
- 28
- 51
- 42
- 34
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.49 | ||
| Price to Tang. Book | 7.09 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 4.94 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -6.64% | ||
| Return on Equity | -6.63% | ||
| Operating Margin | -169.09% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 160 | 254 | 50.52 | 116.29 | 228.82 | 244.39 | 241.09 | -14.37% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Octave Specialty Group, Inc. is a global specialty insurance company that builds, buys, and scales niche insurance distribution and underwriting businesses. It provides strategic direction, risk oversight, data and technology solutions, and capital support to MGA businesses operating across the U.S., U.K., and Bermuda. Its build-and-buy strategy is executed by its incubation division, Octave Ventures, and its acquisition division, Octave Partners. At Octave Ventures, it helps specialty underwriters to set up their own company, leveraging its resources. It offers funding, infrastructure, risk capital, and A+ rated paper as well as experienced guidance and support to underwriters looking to launch their own MGAs. Octave Partners identifies high-performing MGAs that would benefit from its partnership and add value to its expanding portfolio. To facilitate growth, it provides expertise, technology, distribution and capacity relationships, expansion and cross-company sales opportunities.
Directors
- Jeffrey Stein NEC (51)
- Claude LeBlanc PRE (55)
- David Trick CFO (49)
- Robert Eisman CAO (53)
- Michael Reilly CAD (64)
- Stephen Ksenak GCN (55)
- David Barranco SMD (51)
- R. Sharon Smith SMD (49)
- Lisa Iglesias DRC (55)
- Ian Haft IND (50)
- David Herzog IND (61)
- Joan Lamm-Tennant IND (68)
- Claude Prieur IND (70)
- Last Annual
- December 31st, 2024
- Last Interim
- September 30th, 2025
- Incorporated
- April 29th, 1991
- Public Since
- July 10th, 1991
- No. of Shareholders
- 27
- No. of Employees
- 380
- Sector
- Insurance
- Industry
- Financials
- Exchange
New York Stock Exchange- Shares in Issue
- 43,812,035
- Address
- One World Trade Center, 41st Floor, NEW YORK, 10007
- Web
- https://octavegroup.com/
- Phone
- +1 2126587470
- Contact
- Charles Sebaski
- Auditors
- KPMG LLP
Latest News for AMBC
Upcoming Events for AMBC
Q4 2025 Octave Specialty Group Inc Earnings Release
Q1 2026 Octave Specialty Group Inc Earnings Release
Similar to AMBC
Aegon
New York Stock Exchange
Aflac
New York Stock Exchange
Allstate
New York Stock Exchange
American Financial
New York Stock Exchange
American Integrity Insurance
New York Stock Exchange
FAQ
As of Today at 09:14 UTC, shares in Octave Specialty are trading at $9.52. This share price information is delayed by 15 minutes.
Shares in Octave Specialty last closed at $9.52 and the price had moved by -21.32% over the past 365 days. In terms of relative price strength the Octave Specialty share price has underperformed the S&P500 Index by -31.41% over the past year.
The overall consensus recommendation for Octave Specialty is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreOctave Specialty does not currently pay a dividend.
Octave Specialty does not currently pay a dividend.
Octave Specialty does not currently pay a dividend.
To buy shares in Octave Specialty you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $9.52, shares in Octave Specialty had a market capitalisation of $417.09m.
Here are the trading details for Octave Specialty:
- Country of listing: United States
- Exchange: NYQ
- Ticker Symbol: AMBC
Based on an overall assessment of its quality, value and momentum Octave Specialty is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Octave Specialty is $12.50. That is 31.3% above the last closing price of $9.52.
Analysts covering Octave Specialty currently have a consensus Earnings Per Share (EPS) forecast of -$0.67 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Octave Specialty. Over the past six months, its share price has outperformed the S&P500 Index by +4.86%.
As of the last closing price of $9.52, shares in Octave Specialty were trading +12.09% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Octave Specialty PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $9.52.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Octave Specialty's management team is headed by:
- Jeffrey Stein - NEC
- Claude LeBlanc - PRE
- David Trick - CFO
- Robert Eisman - CAO
- Michael Reilly - CAD
- Stephen Ksenak - GCN
- David Barranco - SMD
- R. Sharon Smith - SMD
- Lisa Iglesias - DRC
- Ian Haft - IND
- David Herzog - IND
- Joan Lamm-Tennant - IND
- Claude Prieur - IND